Lineages and sublineages of human papillomavirus type 16 in cervical samples of Iranian women

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2020 (2020).
  Google Scholar
• 2. Xu H-H, Zheng L-Z, Lin A-F. Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China. Gene 647, 192–197 (2018).
  Medline CASGoogle Scholar
• 3. Shepherd JH. Cervical cancer. Best practice & research Clinical obstetrics & gynaecology. 26(3), 293–309 (2012).
  MedlineGoogle Scholar
• 4. Eftekhar NS, Karbalaie Niya MH, Yazdani F et al. Genotype distribution of Human Papillomavirus (HPV) in patients with Recurrent Respiratory Papillomatosis (RRP) in Iran. Respir. Med. 132, 270 (2017).
  Google Scholar
• 5. Karbalaie Niya MH, Tameshkel FS, Panahi M et al. Human Papillomavirus Investigation in Head and Neck Squamous Cell Carcinoma: Initial Report from the Low Risk HPV Types Associations. Asian Pacific journal of cancer prevention. 18(9), 2573 (2017).
  MedlineGoogle Scholar
• 6. Doorbar J, Quint W, Banks L et al. The biology and life-cycle of human papillomaviruses. Vaccine 30, F55–F70 (2012).
  Medline CASGoogle Scholar
• 7. Nguyen HP, Ramírez-Fort MK, Rady PL. The biology of human papillomaviruses. Human Papillomavirus. 45, 19–32 (2014).
  Google Scholar
• 8. Guan P, Howell-Jones R, Li N et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 131(10), 2349–2359 (2012).
  Medline CASGoogle Scholar
• 9. Jalilvand S, Shoja Z, Hamkar R. Human papillomavirus burden in different cancers in Iran: a systematic assessment. Asian Pac J Cancer Prev. 15(17), 7029–7035 (2014).
  MedlineGoogle Scholar
• 10. Lambie M, Bratman SV. Fundamental Biology of Human Papillomaviruses. Recurrent Respiratory Papillomatosis Springer, Cham (2018).1–17
  Google Scholar
• 11. Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer 123(12), 2219–2229 (2017).
  MedlineGoogle Scholar
• 12. Gheit T, Cornet I, Clifford GM et al. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiology and Prevention Biomarkers. 20(7), 1315–1321 (2011).
  MedlineGoogle Scholar
• 13. Maucort-Boulch D, Plummer M, Castle PE et al. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int. J. Cancer 126(3), 684–691 (2010).
  Medline CASGoogle Scholar
• 14. Chen Z, Schiffman M, Herrero R et al. Classification and evolution of human papillomavirus genome variants: alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516, 86–101 (2018).
  Medline CASGoogle Scholar
• 15. Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology 445(1–2), 232–243 (2013). •• The comperehensive classification of lineages and sulineages of several HPV genotypes.
  Medline CASGoogle Scholar
• 16. Yamada T, Wheeler CM, Halpern AL et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69(12), 7743–7753 (1995).
  Medline CASGoogle Scholar
• 17. Yamada T, Manos MM, Peto J et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71(3), 2463–2472 (1997).
  Medline CASGoogle Scholar
• 18. Huertas-Salgado A, Martín-Gámez DC, Moreno P et al. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology 410(1), 201–215 (2011).
  Medline CASGoogle Scholar
• 19. Clifford GM, Tenet V, Georges D et al. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res. 7, 67–74 (2019). •• A comperehensive study regard to HPV16 lineages and sublineages in the world.
  MedlineGoogle Scholar
• 20. von Knebel Doeberitz M. HPV 16 and its variants: minor genome variations make a big difference. J. Natl Cancer Inst. 108(9), djw123 (2016).
  MedlineGoogle Scholar
• 21. Kumar A, Hussain S, Yadav IS et al. Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes. J. Virol. Methods 218, 51–58 (2015).
  Medline CASGoogle Scholar
• 22. Mandal P, Bhattacharjee B, Sen S et al. Complete genome sequences of eight human papillomavirus type 16 Asian American and European variant isolates from cervical biopsies and lesions in Indian women. Genome announcements. 4(3), e00243–16 (2016).
  MedlineGoogle Scholar
• 23. Nicolás-Párraga S, Alemany L, de Sanjose S et al. Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma. Int. J. Cancer 140(9), 2092–2100 (2017).
  Medline CASGoogle Scholar
• 24. Khorasanizadeh F, Hassanloo J, Khaksar N et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women – analyses of national data and systematic review of the literature. Gynecol. Oncol. 128(2), 277–281 (2013).
  MedlineGoogle Scholar
• 25. Jalilvand S, Shoja Z, Nourijelyani K et al. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: implications for screening and vaccination. J. Med. Virol. 87(2), 287–295 (2015).
  MedlineGoogle Scholar
• 26. Vaezi T, Shoja Z, Hamkar R et al. Human papillomavirus type 16 lineage analysis based on E6 region in cervical samples of Iranian women. Infect Genet Evol. 55, 26–30 (2017). • First report of HPV16 lineages and sublineages in Iran.
  Medline CASGoogle Scholar
• 27. Mobini Kesheh M, Barazandeh M, Kaffashi A et al. Genetic Diversity of HPV 16 and HPV 18 Based on Partial Long Control Region in Iranian Women. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022, 4759871 (2022).
  Google Scholar
• 28. Poljak M, Kocjan BJ. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert review of anti-infective therapy. 8(10), 1139–1162 (2010).
  Medline CASGoogle Scholar
• 29. Shang Q, Wang Y, Fang Y et al. Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China. J. Clin. Microbiol. 49(7), 2656–2663 (2011).
  Medline CASGoogle Scholar
• 30. Bhattacharjee B, Mandal NR, Roy S et al. Characterization of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 377(1), 143–150 (2008).
  Medline CASGoogle Scholar
• 31. Mobini Kesheh M, Barazandeh M, Kaffashi A et al. Genetic diversity of HPV 16 and HPV 18 based on partial long control region in Iranian women. Can J Infect Dis Med Microbiol. 2022, 4759871 (2022). • A new study regard to HPV16 lineages and sublineages in Iran.
  MedlineGoogle Scholar
• 32. Cornet I, Gheit T, Iannacone MR et al. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 108(1), 240 (2013).
  Medline CASGoogle Scholar
• 33. Cornet I, Gheit T, Franceschi S et al. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 86(12), 6855–6861 (2012).
  Medline CASGoogle Scholar
• 34. Xi LF, Kiviat NB, Hildesheim A et al. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl Cancer Inst. 98(15), 1045–1052 (2006).
  MedlineGoogle Scholar
• 35. Matsumoto K, Yoshikawa H, Nakagawa S et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett. 156(2), 159–165 (2000).
  Medline CASGoogle Scholar
• 36. Berumen J, Ordonez RM, Lazcano E et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl Cancer Inst. 93(17), 1325–1330 (2001).
  Medline CASGoogle Scholar
• 37. Lizano M, De la Cruz-Hernández E, Carrillo-García A et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol. Oncol. 102(2), 230–235 (2006).
  MedlineGoogle Scholar
• 38. Tornesello ML, Duraturo ML, Salatiello I et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J. Med. Virol. 74(1), 117–126 (2004).
  Medline CASGoogle Scholar
• 39. Freitas LB, Chen Z, Muqui EF et al. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLOS ONE. 9(7), e100746 (2014).
  MedlineGoogle Scholar
• 40. Hildesheim A, Schiffman M, Bromley C et al. Human papillomavirus type 16 variants and risk of cervical cancer. J NatlCancer Inst. 93(4), 315–318 (2001).
  Medline CASGoogle Scholar
• 41. Schiffman M, Rodriguez AC, Chen Z et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 70(8), 3159–3169 (2010).
  Medline CASGoogle Scholar
• 42. Sichero L, Ferreira S, Trottier H et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 120(8), 1763–1768 (2007).
  Medline CASGoogle Scholar
• 43. Zuna RE, Moore WE, Shanesmith RP et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 125(11), 2609–2613 (2009).
  Medline CASGoogle Scholar
• 44. Zhang E-Y, Tang X-D. Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pacific Journal of Cancer Prevention. 13(11), 5363–5369 (2012).
  MedlineGoogle Scholar
• 45. Pol SBV, Klingelhutz AJ. Papillomavirus E6 oncoproteins. Virology 445(1–2), 115–137 (2013).
  MedlineGoogle Scholar
• 46. Gokhale PS, Sonawani A, Idicula-Thomas S et al. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants. J. Med. Virol. 86(6), 968–974 (2014).
  MedlineGoogle Scholar
• 47. Pillai M, Hariharan R, Babu JM et al. Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int. J. Cancer 125(1), 91–103 (2009).
  Medline CASGoogle Scholar
• 48. Zehbe I, Richard C, DeCarlo CA et al. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383(1), 69–77 (2009).
  Medline CASGoogle Scholar
• 49. Pimenoff VN, de Oliveira CM, Bravo IG. Transmission between archaic and modern human ancestors during the evolution of the oncogenic human papillomavirus 16. Mol. Biol. Evol. 34(1), 4–19 (2017).
  Medline CASGoogle Scholar